Toggle navigation
Home
Company directory
Life science ecosystem
A whole range of premises
Living and working
Team
Media
Accueil
»
Media
Media
Press releases
Download the press releases on SMO Biopôle Clermont-Limagne and its members.
Search
types de communiqués
SMO Biopôle Clermont-Limagne
Companies
Alphanosos
Aptys Pharma
Carbios
Carbogen Amcis
GIMRA
Greencell
Horée cosmétiques
Icare
Jacquet
Limagrain
METabolic EXplorer
Oncosema
Sabi Agri
SMO Biopôle Clermont-Limagne
Valbiotis
Végépolys Valley
14/09/2023
- Valbiotis
Valbiotis presents the full results of the Phase II/III REVERSE-IT study : impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes, a first for a non-drug active substance.
28/07/2023
- METabolic EXplorer
First-half 2023 consolidated turnover (IN FRENCH).
10/07/2023
- Oncosema
Deeptech start-up and mission oriented company, Oncosema is the winner of the I-LAB Innovation competition (IN FRENCH).
03/07/2023
- Valbiotis
Valbiotis announces the appointment of Charlotte JEZEQUEL as Director of Human Relations and Executive Committee member.
19/06/2023
- Limagrain
Press Kit- The Limagrain wheat industry (IN FRENCH).
13/06/2023
- METabolic EXplorer
METabolic EXplorer publishes its Sustainability 2022 report (IN FRENCH).
22/05/2023
- Valbiotis
Valbiotis announces the large success of the REVERSE-IT international multicentric Phase II/III clinical study on TOTUM•63: proven efficacy on the main risk factor of developing type 2 diabetes.
05/05/2023
- METabolic EXplorer
Q1 2003 Financial Information (IN FRENCH).
18/04/2023
- Limagrain
Limagrain starts its recruitment campaign! 600 seasonal crops are expected for its summer and autumn harvests (IN FRENCH).
14/04/2023
- Valbiotis
Valbiotis announces its Combined Shareholders General Meeting will be held on May 2, 2023.
03/04/2023 - SMO Biopôle Clermont-Limagne
The pharmaceutical site of Riom La Varenne for 10 years within the SMO Biopôle Clermont-Limagne (IN FRENCH).
30/03/2023
- METabolic EXplorer
F22 – 2023 beginnings and Outlook (IN FRENCH).
13/03/2023
- Valbiotis
Valbiotis announces the last visit of the last patient in the Phase II/III REVERSE-IT study on TOTUM•63, in partnership with Nestlé Health Science.
09/02/2023
- METabolic EXplorer
2022 turnover: €226.6 million (IN FRENCH).
07/02/2023
- METabolic EXplorer
Approval of the agreement concluded by METabolic EXplorer with its main partners on 23 December 2022 under the conciliation procedure (IN FRENCH).
03/02/2023
- Carbogen Amcis
Inauguration of the new production unit of CARBOGEN AMCIS SAS at Biopôle Clermont-Limagne (Saint-Beauzire, Puy de Dôme) Friday, February 3, 2023 (IN FRENCH).
30/01/2023
- Valbiotis
Valbiotis announces positive results in the bioavailability and mode of action TOTUM•854 clinical study, against high blood pressure.
27/01/2023
- METabolic EXplorer
Provisional suspension of the liquidity contract (IN FRENCH).
13/01/2023
- METabolic EXplorer
2023 Financial Schedule (IN FRENCH).
12/01/2023
- METabolic EXplorer
Provision of preparatory documents for the Extraordinary General Assembly (IN FRENCH).
« Previous
1
2
3
4
5
…
8
Next »
